1-6 of 6
Serena Dalto
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Posttransplantation cyclophosphamide and sirolimus for prevention of GVHD after HLA-matched PBSC transplantation

Clinical Trials & Observations
Raffaella Greco, Francesca Lorentino, Mara Morelli, Fabio Giglio, Daniele Mannina, Andrea Assanelli, Sara Mastaglio, Serena Dalto, Tommaso Perini, Lorenzo Lazzari, Simona Piemontese, Consuelo Corti, Magda Marcatti, Massimo Bernardi, Maria Teresa Lupo Stanghellini, Fabio Ciceri, Jacopo Peccatori
Journal: Blood
Blood (2016) 128 (11): 1528–1531.
https://doi.org/10.1182/blood-2016-06-723205
Published: 2016
Journal Articles

Brentuximab Vedotin (BV) an Effective Treatment for Autologous (ASCT) and/or Allogeneic (alloSCT) Transplant naïve Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL) : A retrospective Single-Institution Study

Simonetta Viviani, MD, Serena Dalto, MD, Paola Matteucci, MD, Massimo Di Nicola, MD, Anna Guidetti, MD, Liliana Devizzi, MD, Michele Magni, MD, Anna Dodero, MD, Lucia Farina, MD, Francesco Spina, MD, Alessandro M. Gianni, MD, Paolo Corradini, MD
Journal: Blood
Blood (2014) 124 (21): 5428.
https://doi.org/10.1182/blood.V124.21.5428.5428
Published: 2014
Journal Articles

Role of Allogeneic Stem Cell Transplantation (AlloSCT) in Patients Affected By Peripheral T-Cell Lymphomas (PTCL): No Difference in Outcome Between Patients Allografted at Diagnosis and in First Chemosensitive Relapse

Anna Dodero, MD, Francesco Spina, MD, Franco Narni, Francesca Patriarca, MD, Fabio Benedetti, MD, Donatella Baronciani, MD, Alessandro Rambaldi, Attilio Olivieri, MD, Serena Dalto, MD, Benedetto Bruno, MD, Umberto Vitolo, MD, Paolo Corradini, MD
Journal: Blood
Blood (2014) 124 (21): 2574.
https://doi.org/10.1182/blood.V124.21.2574.2574
Published: 2014
Journal Articles

High-Dose Rituximab In The Conditioning Regimen Before Allogeneic Stem Cell Transplantation Decreases Deaths Related To Gvhd Without Affecting The Anti-Lymphoma Effect

Anna Dodero, MD, Francesco Spina, MD PhD, Barbara Sarina, MD, Cristiana Carniti, Francesca Patriarca, MD, Angelo Michele Carella, Alessandro Levis, Alberto Bosi, MD, Michele Falda, MD, Paolo Di Bartolomeo, MD, Francesco Onida, MD, Serena Dalto, MD, Antonio Vendramin, Alessandro Rambaldi, MD, Paolo Corradini
Journal: Blood
Blood (2013) 122 (21): 2059.
https://doi.org/10.1182/blood.V122.21.2059.2059
Published: 2013
Journal Articles

Outcome of Hodgkin's Lymphoma Patients After Reduced-Intensity Allogeneic Stem Cell Transplantation: Complete Remission Status Has the Most Relevant Clinical Impact along with Extranodal Disease and C-Reactive Protein Before Transplant

Lucia Farina, Francesco Spina, Anna Dodero, Simonetta Viviani, Vittorio Montefusco, Raffaella Milani, MD, Serena Dalto, Jacopo Mariotti, Carmelo Carlo-Stella, Paolo Corradini
Journal: Blood
Blood (2010) 116 (21): 3542.
https://doi.org/10.1182/blood.V116.21.3542.3542
Published: 2010
Journal Articles

Long-Term Follow-up of Patients Affected by Relapsed Lymphomas Receiving Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (Allo-SCT): An Update of the Phase II Study of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Paolo Corradini, MD, Anna Dodero, MD, Lucia Farina, MD, Roberto Fanin, MD, Francesca Patriarca, MD, Rosalba Miceli, MD, Paola Matteucci, MD, Fabio Ciceri, MD, Rosanna Scime’, MD, Franco Narni, MD, Enrico Pogliani, MD, Anna Locasciulli, MD, Serena Dalto, MD, Cristiana Carniti, PhD, Andrea Bacigalupo, MD, Alessandro Rambaldi, Francesca Bonifazi, MD, Attilio Olivieri, MD, Mats L Brune, MD, Alessandro M. Gianni, MD, Corrado Tarella, MD
Journal: Blood
Blood (2008) 112 (11): 3303.
https://doi.org/10.1182/blood.V112.11.3303.3303
Published: 2008